Form EFFECT SAB Biotherapeutics,
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | January 7, 2026 5:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- The Roofing List Launches Nationwide Directory of More Than 50,000 Roofing Contractors
- Best Crypto to Invest In: Citi Backs Aave as HYPE and ADA Pull Back and Remittix Earn Readies Aave, Morpho and Fluid Pools
- Doginal Dogs Announces DDMIAMI 2026 Schedule, Including an In-Person Card Championship
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share